https://support.google.com/admanager/thread/323330589?hl=en&sjid=3715489950630578874-NA

  In-licensing has become a cornerstone strategy for many pharmaceutical and biotechnology companies looking to expand their portfolios without bearing the full financial burden associated with R&D. This strategic approach allows companies to acquire rights to innovative products or technologies from other firms, enabling them to tap into new markets, accelerate product development,...